122 related articles for article (PubMed ID: 6888648)
1. Altered metabolic incorporation of fucose and leucine into PNS myelin of 25-week-old diabetic (C57BL/Ks [db/db]) mice: effects of untreated diabetes on nerve metabolism.
Chez MG; Peterson RG
Neurochem Res; 1983 Apr; 8(4):465-72. PubMed ID: 6888648
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of fucose and leucine into PNS myelin proteins in nerves undergoing early Wallerian degeneration.
Peterson RG; Baughman S; Scheidler DM
Neurochem Res; 1981 Feb; 6(2):213-23. PubMed ID: 7242779
[TBL] [Abstract][Full Text] [Related]
3. The effect of diabetes on leucine and fucose incorporation into PNS myelin proteins.
Baughman S; Felten SY; Lee W; Moore SA; O'Connor BL; Peterson RG
Horm Metab Res; 1981 Jun; 13(6):331-5. PubMed ID: 7262834
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of peripheral nerve myelin in experimental diabetes.
Spritz N; Singh H; Marinan B
J Clin Invest; 1975 May; 55(5):1049-56. PubMed ID: 123535
[TBL] [Abstract][Full Text] [Related]
5. Effects of inhibitors of oligosaccharide processing on P0 protein synthesis and incorporation into PNS myelin.
Smith ME
J Neurochem; 1991 Aug; 57(2):655-64. PubMed ID: 1712832
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of entry P0 protein into peripheral nerve myelin.
Rapaport RN; Benjamins JA
J Neurochem; 1981 Jul; 37(1):164-71. PubMed ID: 7252501
[TBL] [Abstract][Full Text] [Related]
7. Alteration of fucose/leucine incorporation into PNS myelin by isoniazid neuropathy.
Colip MP; Baughman S; Peterson RG
J Neurobiol; 1981 Mar; 12(2):193-7. PubMed ID: 6260895
[No Abstract] [Full Text] [Related]
8. Phospholipid metabolism and protein phosphorylation in sciatic nerve from genetically diabetic (db/db) mouse.
Berti-Mattera LN; Eichberg J
Diabetes; 1988 Dec; 37(12):1703-7. PubMed ID: 2461325
[TBL] [Abstract][Full Text] [Related]
9. [35-S]sulfate incorporation into myelin clycoproteins; II. Peripheral nervous tissue.
Matthieu JM; Everly JL; Brady RO; Quarles RH
Biochim Biophys Acta; 1975 May; 392(1):167-74. PubMed ID: 1125325
[TBL] [Abstract][Full Text] [Related]
10. Degenerative neuropathy in insulin-treated diabetic rats.
Westfall SG; Felten DL; Mandelbaum JA; Moore SA; Peterson RG
J Neurol Sci; 1983 Sep; 61(1):93-107. PubMed ID: 6355399
[TBL] [Abstract][Full Text] [Related]
11. Relationship of ATP turnover, polyphosphoinositide metabolism, and protein phosphorylation in sciatic nerve and derived peripheral myelin subfractions from normal and streptozotocin diabetic rats.
Lowery JM; Berti-Mattera LN; Zhu X; Peterson RG; Eichberg J
J Neurochem; 1989 Mar; 52(3):921-32. PubMed ID: 2465383
[TBL] [Abstract][Full Text] [Related]
12. Sciatic nerve ATPase activity is unaffected in diabetic mutant C57Bl/Ks (db/db) mice.
Bianchi R; Boccasavia E; Vittadello M; Schiavinato A; Gorio A
Diabetes; 1987 Sep; 36(9):1082-5. PubMed ID: 2956143
[TBL] [Abstract][Full Text] [Related]
13. Evidence that the major protein in rat sciatic nerve myelin is a glycoprotein.
Everly JL; Brady RO; Quarles RH
J Neurochem; 1973 Aug; 21(2):329-34. PubMed ID: 4724321
[No Abstract] [Full Text] [Related]
14. Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesity, peripheral diabetic polyneuropathy, and the metabolic syndrome.
Nowicki M; Kosacka J; Serke H; Blüher M; Spanel-Borowski K
J Neurosci Res; 2012 Jan; 90(1):122-31. PubMed ID: 21919033
[TBL] [Abstract][Full Text] [Related]
15. Nodal gap substance in diabetic nerve.
Seneviratne KN; Weerasuriya A
J Neurol Neurosurg Psychiatry; 1974 May; 37(5):502-13. PubMed ID: 4276085
[TBL] [Abstract][Full Text] [Related]
16. Neuroactive steroid treatment modulates myelin lipid profile in diabetic peripheral neuropathy.
Mitro N; Cermenati G; Brioschi E; Abbiati F; Audano M; Giatti S; Crestani M; De Fabiani E; Azcoitia I; Garcia-Segura LM; Caruso D; Melcangi RC
J Steroid Biochem Mol Biol; 2014 Sep; 143():115-21. PubMed ID: 24607810
[TBL] [Abstract][Full Text] [Related]
17. Ganglioside treatment of genetic and alloxan-induced diabetic neuropathy.
Gorio A; Aporti F; Di Gregorio F; Schiavinato A; Siliprandi R; Vitadello M
Adv Exp Med Biol; 1984; 174():549-64. PubMed ID: 6204518
[TBL] [Abstract][Full Text] [Related]
18. Alteration of phosphoinositide metabolism, protein phosphorylation, and carbohydrate levels in sciatic nerve from Wistar fatty diabetic rats.
Berti-Mattera LN; Lowery J; Day SF; Peterson RG; Eichberg J
Diabetes; 1989 Mar; 38(3):373-8. PubMed ID: 2537246
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of myelin, particulate, and soluble protein subfractions of rat sciatic nerve during the early stage of Wallerian degeneration: a comparison of metabolic studies using double and single isotope methods and recovery.
Bell ME; Peterson RG; Wiggins RC
Neurochem Res; 1982 Jan; 7(1):99-114. PubMed ID: 7040996
[TBL] [Abstract][Full Text] [Related]
20. Altered protein phosphorylation in sciatic nerve from rats with streptozocin-induced diabetes.
Schrama LH; Berti-Mattera LN; Eichberg J
Diabetes; 1987 Nov; 36(11):1254-60. PubMed ID: 3666317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
